BioNxt Solutions Inc. (OTCMKTS:BNXTF) Sees Large Decline in Short Interest

BioNxt Solutions Inc. (OTCMKTS:BNXTF) saw a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 1,000 shares, a decline of 93.3% from the February 28th total of 15,000 shares. Based on an average trading volume of 16,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the company’s stock are sold short.

BioNxt Solutions Trading Down 8.3 %

OTCMKTS:BNXTF traded down $0.03 during midday trading on Friday, hitting $0.36. 300 shares of the company were exchanged, compared to its average volume of 9,967. BioNxt Solutions has a fifty-two week low of $0.11 and a fifty-two week high of $0.43. The company has a market capitalization of $40.82 million, a PE ratio of -9.00 and a beta of 0.62. The company has a fifty day simple moving average of $0.34 and a 200 day simple moving average of $0.25.

BioNxt Solutions Company Profile

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.